Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02538614
Title Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications

chronic lymphocytic leukemia

Therapies

BI 836826 + Idelalisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.